Ledger.Open graph →
SEC Form D · filed January 11, 2023

Luminary Therapeutics, Inc

Offering
$2.8M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minneapolis, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Jeff Liter · Minneapolis, MNExec · Director · PromoterMark Chance · Minneapolis, MNDirectorTracey Lodie · Minneapolis, MNDirectorDavid Largaespada · Minneapolis, MNDirector · PromoterJames Haymaker · Minneapolis, MNDirectorJohn Wells · Minneapolis, MNDirectorJohn Hurley · Minneapolis, MNExecGeorge Cox · Minneapolis, MNDirectorChristopher J. Kocourek · MINNEAPOLIS, MNExecMichael Falk · West Palm Beach, FLDirectorRobert O'Sullivan · West Palm Beach, FLDirector · PromoterBenjamin A. Lincoln · Santa Monica, CADirectorC. R. Carter · Atlanta, GADirectorDouglas E. Mark · MINNEAPOLIS, MNExec · Director · PromoterJason Gelberd · West Palm Beach, FLDirectorPeter Kosa · Minneapolis, MNDirectorMichael Aceti · Needham, MADirectorDean Eliott · Needham, MADirectorJoseph Arboleda-Valasquez · Needham, MAExecSteven J. Speck, Ii · BOWLING GREEN, OHExec · Director · PromoterJosh Harris · New York, NYDirector · PromoterEvan Zemsky · New York, NYDirectorMark S. Feldman · Dallas, TXDirectorPeter Kosa · Minneapolis, MNDirectorGeorge Cox · Minneapolis, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗